HighQC™ Human Mobilized Peripheral Blood CD133+ Stem/Progenitor Cells

Description

HighQC™ Human Mobilized Peripheral Blood CD133+ Stem/Progenitor Cells are isolated from mobilized human peripheral blood. CD133 is a well-established marker for primitive hematopoietic and endothelial progenitors. These cells exhibit high clonogenicity, long-term culture potential, and multipotency. These mobilized peripheral blood CD133+ cells are widely used in regenerative studies, particularly in applications related to angiogenesis, neurogenesis, and cardiac repair. Their early progenitor status and strong regenerative potential make them an ideal candidate for translational and clinical research. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.